|
|
|
World urges Biden not to hoard Coronavirus vaccine
|
|
|
|
Top Stories |
|
|
|
|
IANS | 16 Apr, 2021
From the owner of the biggest producer of one of the Coronavirus
vaccines in India to several senators in the US, a wide range of people
have appealed to US President Joe Biden to temporarily suspend the
intellectual property rules for the vaccine production.
As the
second wave of the Coronavirus pandemic intensifies, India has appealed
to the WTO to waive off the rules so that it can scale up the Covid-19
vaccine production. The virus which originated in Wuhan in 2019 has
killed around 3 million people so far. In India alone, 170,000 people
have died due to the contagious disease.
CEO and owner of Serum
Institute Pune-the biggest manufacturer of Oxford-AstraZeneca Covid-19
vaccine, Adar Poonawalla, in a tweet which went viral, requested the
Biden administration to lift the embargo on raw material exports out of
the US. "If we are to truly unite in beating this virus, on behalf of
the vaccine industry outside the U.S., I humbly request you to lift the
embargo of raw material exports out of the U.S. so that vaccine
production can ramp up. Your administration has the details," he
tweeted.
At least ten senators in a letter to President Biden
said the US should prioritise people over pharmaceutical company profits
and support the temporary waiver of the rules. A waiver could pave the
way for generic or other manufactures to make more vaccines, media
reports quoted the letter led by Senator Bernie Sanders.
A group
of 170 world leaders and Nobel laureates earlier sent a similar letter
to Biden urging him to support a temporary waiver of the WTO's
intellectual property rules.
India's China expert Brahma
Chellaney lashed out at the US for hoarding raw material. "As if Biden's
vaccine hoarding policy during a global crisis wasn't bad enough, he
also has restricted export of key raw materials, affecting vaccine
production in India. Yet the mainstream US media has ignored the global
impacts of the dual U.S. hoarding.
Possibly influenced by
Poonawalla's tweet, the government on Friday announced that it will
help scale production for locally manufactured Covaxin vaccine, from 10
million/month in April to 100 million/month by September 2021.
"The
current production capacity of indigenously developed Covaxin vaccine
will be doubled by May-June 2021 and then increased nearly 6-7 fold by
July - August 2021 i.e increasing the production from 1 crore vaccine
doses in April, 2021 to 6-7 crore vaccine dose/month in July - August.
It is expected to reach nearly 10 crore doses per month by Sep 2021,"
the government said in an official statement.
Capacities of
Bharat Biotech Limited, Hyderabad as well as other public sector
manufactures are being upgraded with required infrastructure and
technology, the government said. At least three public sectors
companies are also being supported to increase the capacity of vaccine
production.
|
|
|
|
|
|
|
|
|
|
|
|
|
Customs Exchange Rates |
Currency |
Import |
Export |
US Dollar
|
66.20
|
64.50 |
UK Pound
|
87.50
|
84.65 |
Euro
|
78.25
|
75.65 |
Japanese
Yen |
58.85 |
56.85 |
As on 13 Aug, 2022 |
|
|
Daily Poll |
|
|
PM Modi's recent US visit to redefine India-US bilateral relations |
|
|
|
|
|
Commented Stories |
|
|
|
|
|
|
|
|